Bailard, Inc. Organogenesis Holdings Inc. Transaction History
Bailard, Inc.
- $3.8 Billion
- Q3 2024
A detailed history of Bailard, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Bailard, Inc. holds 42,913 shares of ORGO stock, worth $152,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,913Holding current value
$152,341% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ORGO
# of Institutions
117Shares Held
63.2MCall Options Held
25KPut Options Held
23.2K-
Morgan Stanley New York, NY12MShares$42.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT11.8MShares$42 Million2.88% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$18.1 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M4.84MShares$17.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$13 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $465M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...